RNAi, miRNA and siRNA

Venue: Copthorne Tara Hotel

Location: London, United Kingdom

Event Date/Time: Jun 27, 2011 End Date/Time: Jun 28, 2011
Early Registration Date: Mar 31, 2011
Report as Spam


SMi is proud to announce its 6th annual conference on RNAi, miRNA and siRNA , a now well established meeting ground for pharmaceutical professionals involved in this new and exciting area.

This conference will showcase some of the latest successes in siRNA, miRNA and oligonucleotide therapeutic development, including several presentations on overcoming delivery issues which remains a major barrier in the way of fully realising RNAi’s exiting potential. Also explored, will be the work done in both academia and in major pharmaceutical research on respiratory therapeutics that will look at how both siRNA and miRNA can revolutionise the field, and how best to integrate computational support and screening in aid of such research.

Key Presentation Include:

Opportunities and Challenges in siRNA Therapeutics Development
Laura Sepp-Lorenzino, Senior Director, Merck & Co

Pulmonary delivery of siRNA - Prospects for therapeutic intervention in respiratory disease
Emma Hickman, Research Investigator, Novartis

Manufacture and control of oligonucleotides — a new challenge for CMC
Mike Webb, Head API Chemistry & Analysis UK, GSK

Single stranded antisense - today's situation and the future's potential
Troels Koch, VP, Research Division, Santaris Pharma A/S

RNAi: Developing a New Therapeutic Platform
Rachel Meyers, Vice President, Research and RLD ,Alnylam Pharmaceuticals

Strategies for inhibiting the miRNA pathway
Petr Svoboda, Department of Epigenetic Regulations, Institute of Molecular Genetics


Additional Information

ALSO FEATURING AN INTERACTIVE POST-CONFERENCE WORKSHOP ON: Manipulating exons to treat disease Hosted by: Giles Campion, SVP R&D and CMO, Prosensa 29th June 2011, Copthorne Tara Hotel, London In association with: Prosensa